Kyverna director receives RSU and option grants
Kyverna Therapeutics director Aktar Mert reported equity awards consisting of restricted stock units and stock options.
Rhea-AI Filing Summary
Kyverna Therapeutics director Aktar Mert reported equity awards consisting of restricted stock units and stock options. The filing shows a grant of 5,093 shares of Common Stock as restricted stock units that vest in full on the earlier of May 27, 2027, or immediately before the company’s 2027 annual stockholder meeting, if service continues through that date. Mert also received stock options covering 20,582 shares of Common Stock at an exercise price of $8.59 per share, which become fully vested and exercisable on the same timeline. Following the restricted stock grant, Mert holds 21,727 shares of Common Stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 25,675 shares
Grant/Award
2 txns
Insider
Aktar Mert
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,582 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,093 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 20,582 contracts (Direct);
Common Stock — 21,727 shares (Direct)
Footnotes (2)
- F1. Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- F2. All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Key Figures
RSU grant: 5,093 shares
Stock options granted: 20,582 shares
Option exercise price: $8.59 per share
+3 more
6 metrics
RSU grant
5,093 shares
Restricted stock unit award of Common Stock
Stock options granted
20,582 shares
Options on Common Stock granted to director
Option exercise price
$8.59 per share
Conversion or exercise price for stock options
Option expiration
May 27, 2036
Expiration date of stock options
Shares owned after grant
21,727 shares
Total Common Stock directly held following RSU award
Underlying option shares
20,582 shares
Common Stock underlying the stock option award
Key Terms
restricted stock unit, stock option, vest, exercisable, +1 more
5 terms
restricted stock unit financial
"Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027..."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027..."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vest financial
"which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercisable financial
"All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 27, 2027..."
annual meeting of stockholders financial
"immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service..."
FAQ
What insider transaction did Kyverna Therapeutics (KYTX) report for Aktar Mert?
Kyverna Therapeutics reported that director Aktar Mert received equity awards consisting of restricted stock units and stock options. These awards increase his direct ownership in the company and reflect standard director compensation rather than an open-market purchase or sale.
What stock options were granted to Aktar Mert by Kyverna Therapeutics (KYTX)?
Aktar Mert was granted stock options covering 20,582 shares of Kyverna Therapeutics Common Stock at an exercise price of $8.59. These options become fully vested and exercisable based on time and service conditions tied to the 2027 vesting schedule.
When do Aktar Mert’s Kyverna Therapeutics (KYTX) equity awards vest?
Both the restricted stock units and stock options vest in full on the earlier of May 27, 2027, or immediately before Kyverna’s 2027 annual meeting of stockholders. Vesting is contingent on his continuous service to the company through the applicable date.
Is Aktar Mert’s Kyverna Therapeutics (KYTX) Form 4 a buy or a grant?
The Form 4 reflects grant or award acquisitions, not an open-market buy. Both the restricted stock units and stock options were awarded as compensation, with no purchase price paid for the awards themselves at the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
